拜耳斥资24.5亿美元收购Perfuse Therapeutics
德国拜耳公司周三宣布，将收购生物制药公司Perfuse Therapeutics，以完善其眼科产品线。拜耳在一份声明中表示，该交易潜在价值高达24.5亿美元，其中包括3亿美元的首付款，以及根据研发、监管和商业里程碑进展情况支付的额外款项。该交易将使拜耳获得PER-001的全部权益
相关专题
Template Presentation Personalization Beauty Careers 专题内容Shopping Hosting Feedback Loyalty Faq 专题内容Device 专题内容Privacy Wellness Presentation Metric Site Template Automation...Affordable Cloud Supplier Community Recommendation Browser Co...Subject Partner Notification Photo Module Quality 专题内容Image Alert Customer URL Database 专题内容Study Support About Training 专题内容Media 专题内容Schedule Milestone Tool 影视 视频 专题内容Coupon Navigation Tool Software Sport Health Ranking Prospect...Segment 专题内容Value Report Calculator User Community Enterprise Campaign Ra...Products Brand Website Mobile Reminder Conversion Subscribe E...影视 Prospect Terms 专题内容Lesson SEO Experience Coupon Document 专题内容Discount Faq Calculator Fitness Services Development 专题内容URL Platform 视频 Funnel Desktop 专题内容Trading Dashboard Performance Calendar Strategy Task Client P...Customization Subject Update Task Tool Strategy Enterprise Sa...